EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir

Hatasu Kobayashi, Yurie Mori, Sharif Ahmed, Yuichiro Hirao, Shinya Kato, Shosuke Kawanishi, Mariko Murata, Shinji Oikawa

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiac477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Hatasu Kobayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molnupiravir is an antiviral agent recently used for treating coronavirus disease 2019 (COVID-19). Here, we demonstrate that N4-hydroxycytidine (NHC), a molnupiravir metabolite, treated with cytidine deaminase (CDA) induced Cu(II)-mediated oxidative DNA damage in isolated DNA. A colorimetric assay revealed hydroxylamine generation from CDA-treated NHC. The site specificity of DNA damage also suggested involvement of hydroxylamine in the damage. Furthermore, Cu(I) and H2O2 play an important role in the DNA damage. We propose oxidative DNA damage via CDA-mediated metabolism as a possible mutagenic mechanism of NHC, highlighting the need for careful risk assessment of molnupiravir use in therapies for viral diseases, including COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19HumansSARS-CoV-2Hydrogen PeroxideHydroxylaminesOxidative StressDNA DamageCytidine

Stichwörter der Autor:innen

N 4-hydroxycytidine8-dihydro-2′-deoxyguanosine8-oxo-7DNA damagecytidine deaminasehydroxylaminemolnupiravirreactive oxygen species

Substanzen

Antiviral AgentsHydrogen PeroxideHydroxylaminesmolnupiravirCytidineN(4)-hydroxycytidine

Autor:innen und Institutionen

  • Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
  • Faculty of Pharmacy, Gifu University of Medical Science, Kani, Japan.
  • Mie Prefectural College of Nursing, Tsu, Japan.
  • Radioisotope Experimental Facility, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
  • Faculty of Pharmaceutical Science, Suzuka University of Medical Science, Suzuka, Japan.

Förderung

  • JSPS KAKENHI

Zitieren

APA

Kobayashi, H., Mori, Y., Ahmed, S., Hirao, Y., Kato, S., Kawanishi, S., Murata, M., & Oikawa, S. (2023). Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac477

Vancouver

Kobayashi H, Mori Y, Ahmed S, Hirao Y, Kato S, Kawanishi S, et al. Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac477

BibTeX
@article{Kobayashi2023,
  author = {Kobayashi, Hatasu and Mori, Yurie and Ahmed, Sharif and Hirao, Yuichiro and Kato, Shinya and Kawanishi, Shosuke and Murata, Mariko and Oikawa, Shinji},
  title = {Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiac477}
}
Kostenlos starten →